Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Vertex Pharmaceuticals Incorporated VRTX stock has declined 23.6% in the past six months, mainly due to recent pipeline ...

People don't like online forms (gasp!). And it's not hard to see why: Online forms require extra work (and time) and typically stand in the way of a consumer's getting what he or she really wants—such ...

We'll compare five of the best IDP platforms available in 2025, covering what they do well, where they may fall short, and ...

Sydney Roosters star Mark Nawaqanitawase looks to be an increasingly good chance to feature in this autumn’s Ashes series after underlining his credentials again on Friday evening with another ...

Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here ...

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.

(RNS) — The late princess asked, ‘Can I have a chat?’ before surprising him with questions about his religion and about marriage between a Muslim and a Protestant Christian, the photographer told ...

The Staunton-Augusta-Waynesboro region is testing a new P25 Digital Trunked radio system for public safety personnel. This $15 million upgrade will improve radio coverage, eliminate dead spots, and ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...